Cofco Biotechnology Co (SZSE:000930) Long-Term Capital Lease Obligation : ¥195 Mil (As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Cofco Biotechnology Co Long-Term Capital Lease Obligation?

Cofco Biotechnology Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥195 Mil.

Cofco Biotechnology Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (¥131 Mil) to Dec. 2023 (¥197 Mil) but then declined from Dec. 2023 (¥197 Mil) to Mar. 2024 (¥195 Mil).

Cofco Biotechnology Co's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (¥117 Mil) to Dec. 2022 (¥106 Mil) but then increased from Dec. 2022 (¥106 Mil) to Dec. 2023 (¥197 Mil).

Cofco Biotechnology Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Cofco Biotechnology Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cofco Biotechnology Co Long-Term Capital Lease Obligation Chart

Cofco Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

121.73

117.30

105.63

196.64

Cofco Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															104.41	101.02	131.46	196.64	194.97

Cofco Biotechnology Co (SZSE:000930) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Cofco Biotechnology Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cofco Biotechnology Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cofco Biotechnology Co (SZSE:000930) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Cofco Biotechnology Co Ltd (SZSE:000930) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8 Jianguomen Nei Avenue, 7th Floor, Tower A, COFCO Plaza, Dongcheng District, Beijing, CHN, 100005

Website

http://www.zlahsh.com

Cofco Biotechnology Co Ltd is an agricultural product processing enterprises in China. Its products include fuel ethanol, citric acid, L-lactic acid, ethylene oxide, amino acids, fats, fruit juice, and gluten meal, Fuel ethanol, organic fertilizer and others.

Executives

Zhang De Guo	Directors, executives
Wang Yu	Executives
Pan Xi Chun	Secretary Dong
Tong Yi	Director
Sun Deng Bao	Executives
Li Bei	Directors, executives
Xia Ling He	Director
Zou Pei Jun	Executives
Wang De Wen	Executives
Yue Guo Jun	Director
Shi Gong Zhi	Executives
Cai Qi Hai	Executives

Cofco Biotechnology Co (SZSE:000930) Headlines

No Headlines